Image

Global Topical Non-Steroidal Anti-Inflammatory Drugs Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Topical Non-Steroidal Anti-Inflammatory Drugs Market, By Indication (Anti-inflammatory, Analgesic, Swelling, Stiffness, Skin Infections), Drug Type (Branded, Generics), Age Group (Pediatric, Adult, Geriatric), Dosage Form (Creams, Gel, Ointment, Spray, Rubs, Solution, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029

Topical Non-Steroidal Anti-Inflammatory Drugs Market

Topical Non-Steroidal Anti-Inflammatory Drugs Market Analysis and Size

NSAIDs are commonly used to treat pain associated with a range of illnesses, including arthritic conditions, but their effectiveness is sometimes restricted by dose-dependent adverse events (AEs) such as gastrointestinal disturbances, cardiovascular events, and renal toxicity. The use of topical formulations, which have the ability to provide analgesic doses locally, at the site of inflammation, while limiting systemic concentrations, could lessen the risk of such side effects. Diclofenac sodium 1.5 percent topical solution (including dimethyl sulfoxide as a penetration enhancer), diclofenac sodium gel 1 percent, and a diclofenac hydroxyethylpyrrolidine 1.3 percent patch are the only topical treatments currently approved in the United States.

Data Bridge Market Research analyses that the topical non-steroidal anti-inflammatory drugs market was valued at USD 2,517.73 million in 2021 and is expected to reach USD 3,776.90 million by 2029, registering a CAGR of 5.20% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Nonsteroidal anti-inflammatory drugs (NSAIDs) are creams, gels, rubs, solutions, or sprays that include a nonsteroidal anti-inflammatory agent and are designed to be administered directly to the skin overlaying a painful joint or bone area. They're used to treat arthritic symptoms including inflammation, edema, and stiffness and decrease pain. Topical nonsteroidal anti-inflammatory drugs (NSAIDs) can also be used to treat actinic keratosis (a precancerous patch of thick, scaly or crusted skin).

Topical Non-Steroidal Anti-Inflammatory Drugs Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Indication (Anti-inflammatory, Analgesic, Swelling, Stiffness, Skin Infections), Drug Type (Branded, Generics), Age Group (Pediatric, Adult, Geriatric), Dosage Form (Creams, Gel, Ointment, Spray, Rubs, Solution, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Zydus Cadila (India), Boehringer Ingelheim International GmbH. (Germany), Apotex Inc. (Canada), AstraZeneca (UK), Horizon Therapeutics PLC (Ireland), Johnson & Johnson (US), Bayer AG (Germany), Perrigo Company plc (Ireland), Tolmar Pharmaceuticals, Inc. (US), Reckitt Benckiser Group PLC (UK), Sun Pharmaceutical Industries Ltd. (India), Assertio Therapeutics, Inc. (US), DAIICHI SANKYO COMPANY, LIMITED (Japan)

Market Opportunities

 

  • Increase in the number of emerging markets
  • Increase in the number of research and development activities
  • Rising investment for the development of advanced technologies
  • Surging drug approvals and launches

Topical Non-Steroidal Anti-Inflammatory Drugs Market Dynamics

Drivers

  • Rise in the prevalence of pain related diseases

The rise in prevalence of pain related diseases such as keratosis, osteoarthritis and others is anticipated to flourish the growth rate of the market. Along with this, the growing prevalence of chronic disorders will enhance the demand of topical non-steroidal anti-inflammatory drugs market.    

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of topical non-steroidal anti-inflammatory drugs market is the rising healthcare expenditure which helps in improving its infrastructure.

  • Rising geriatric population

The surging number of geriatric population will propel the market's growth rate during the forecast period of 2022-2029. As per the World Ageing 2020 research, the world's population will be roughly 727 million people aged 65 and up in 2020. In 2050, the number of elderly people is expected to increase to 1.5 billion. The geriatric population is more prone to chronic ailments, which is anticipated to enhance the market's growth rate.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the topical non-steroidal anti-inflammatory drugs market. Additionally, high disposable income and rising preference of NSAIDs over other class of pain relievers will result in the expansion of topical non-steroidal anti-inflammatory drugs market.

Opportunities

  • Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the topical non-steroidal anti-inflammatory drugs market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of topical non-steroidal anti-inflammatory drugs during the forecast period.

Restraints/Challenges

On the other hand, high cost associated with drug development and distribution will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and strict regulatory processes linked with product approvals will challenge the market of topical non-steroidal anti-inflammatory drugs. Additionally, side effects linked with topical non-steroidal anti-inflammatory drugs such as nausea, vomiting, dizziness, high blood pressure, and others will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This topical non-steroidal anti-inflammatory drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the topical non-steroidal anti-inflammatory drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Topical non-steroidal anti-inflammatory drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Topical Non-Steroidal Anti-Inflammatory Drugs Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic had delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations have imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The supply chain slowness hampered the topical non-steroidal anti-inflammatory drugs market.

Global Topical Non-Steroidal Anti-Inflammatory Drugs Market Scope

The topical non-steroidal anti-inflammatory drugs market is segmented on the basis of indication, dosage form, drug type, age group, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

  • Anti-inflammatory
  • Analgesic
  • Swelling
  • Stiffness
  • Skin Infections

Drug Type

  • Branded
  • Generics

Dosage Form

  • Creams
  • Gel
  • Ointment
  • Spray
  • Rubs
  • Solution
  • Others

Age Group

  • Pediatric
  • Adult
  • Geriatric

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Topical Non-Steroidal Anti-Inflammatory Drugs Market Regional Analysis/Insights

The topical non-steroidal anti-inflammatory drugs market is analysed and market size insights and trends are provided by country, indication, dosage form, drug type, age group, end-users and distribution channel as referenced above.

The countries covered in the topical non-steroidal anti-inflammatory drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the topical non-steroidal anti-inflammatory drugs market because of the growing number of research and development activities and presence of major key players in this region. Additionally the rising healthcare expenditure will further propel the market's growth rate in this region.

Asia-Pacific is expected to grow during the forecast period due to surging government awareness programs and the increasing geriatric population in this region. Also, the development of healthcare infrastructure and the increasing number of generic drugs will further propel themarket's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Topical Non-Steroidal Anti-Inflammatory Drugs Market Share Analysis

The Topical non-steroidal anti-inflammatory drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to topical non-steroidal anti-inflammatory drugs market.

Some of the major players operating in the topical non-steroidal anti-inflammatory drugs market are:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Sanofi (France), Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • Zydus Cadila (India)
  • Boehringer Ingelheim International GmbH. (Germany)
  • Apotex Inc. (Canada)
  • AstraZeneca (UK)
  • Horizon Therapeutics PLC (Ireland)
  • Johnson & Johnson (US)
  • Bayer AG (Germany)
  • Perrigo Company plc (Ireland)
  • Tolmar Pharmaceuticals, Inc. (US)
  • Reckitt Benckiser Group PLC (UK)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Assertio Therapeutics, Inc. (US)
  • DAIICHI SANKYO COMPANY, LIMITED (Japan) 

Research Methodology: Global Topical Non-Steroidal Anti-Inflammatory Drugs Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The major players operating in the Topical Non-Steroidal Anti-Inflammatory Drugs Market are F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Zydus Cadila (India), Boehringer Ingelheim International GmbH. (Germany), Apotex Inc. (Canada), AstraZeneca (UK), Horizon Therapeutics PLC (Ireland), Johnson & Johnson (US), Bayer AG (Germany), Perrigo Company plc (Ireland), Tolmar Pharmaceuticals, Inc. (US), Reckitt Benckiser Group PLC (UK), Sun Pharmaceutical Industries Ltd. (India), Assertio Therapeutics, Inc. (US), DAIICHI SANKYO COMPANY, LIMITED (Japan).
The significant factors flourishing the growth of the Topical Non-Steroidal Anti-Inflammatory Drugs Market are Rise in the prevalence of pain related diseases, and Increasing investment for healthcare infrastructure.
The Topical Non-Steroidal Anti-Inflammatory Drugs Market is to grow at a CAGR of 5.20% during the forecast by 2029.
The Topical Non-Steroidal Anti-Inflammatory Drugs Market value is expected USD 3,776.90 million by 2029.